If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@NewParksFarm
I do post the information elsewhere, i am trying to introduce VAL to as many investor contacts as possible, if you google the company the LSE forum is right at the top of the list. Hence, new investors would likely visit here to investigate further.
If they arrive here to a flood of posts saying the share price is going to collapse and similar negative posts it could put off the very investors we are trying to attract.
Therefore, imo its essential that the information is quickly found. If i could stick it to the top of the forum i would. We are at £36m mcap for Pete's sake, nobody but nobody should be trying to deramp this stock from this low level base.
You may not agree with me but sentiment plays a VERY big part with AIM Stocks, a negative sentiment is off putting. To prove the point this forum was negative for at least a year, dwelling in negativity and complaining and nobody was interested. The share price coasted as a result. When the exceptional data came out on 201 and it really was good, the SP rallied to 80p BUT rather than get behind VAL and have confidence, the forum members continued to moan, those that had lost faith just cashed out and the rest is history.
That's all changing now, new investors are backing the company, a good percentage of the historic are now supporting, positivity is high, optimism is high and so it should be, we have loads to be positive about here.
Anyhow, close tonight still in the blue and onwards and upwards for tomorrow, one day closer to great news and a major rerate.
GLA
This is what I’m trying to say it’s absolutely pointless I’m pretty sure he thinks some of us investors just stick a pin in before we buy. We know porky we absolutely know market capital etc 201 301 401 please give us a break .
Porky.. Why do you keep putting the same information out on this board daily? We all know it. Try finding somewhere that people haven't heard of VAL and put it there.. Surely that will have more impact?
THIS IS AN INFORMATION REPOST FOR NEW INVESTORS
(Again, Apologies to regulars that have seen this post before but its essential new visitors thinking about investing see it )
Very Quick Synopsis:
An incredibly promising Biotech that accelerates the development of treatments in cancer and women’s health to improve patient lives.
They select and incubate promising novel drug candidates and guide them through an optimised process of development, from pre-clinical studies to clinic to investor-ready assets.
They do not YET have a commercially viable drug but have made significant progress developing both legacy and more recent drug candidates. They are on the cusp of licence deals being completed before the end of this year. The CEO in the Pod Cast with Zac Mir last Sunday confirmed that it will be announceable shortly hence, the increasing interest in the business and increased trading volumes.
The current drug stable includes:
* VAL401 lung/pancreatic cancer drug candidate
* VAL 201 prostate cancer drug candidate
* VAL301 endometriosis drug
* BC201 A Peptide repurposed for anti-inflammatory use
* Lastly, the company’s recent partnership with a London university has its triple-negative breast cancer drug under evaluation, after which Valirx could license the technology under pre-agreed terms.
The clinical results out last September for 201 were great and the recent presentation absolutely fantastic so its all looking good.
BC201 gets largely overlooked by shareholders but could also be a hidden gem. Data due any moment. It could prove to materially reduce long term Covid damage and/or Sepsis, One to watch:
https://www.valirx.com/sites/default/files/2020-10/BlackCat-COVID-19-ARDS-treatment-summary.pdf
As a bonus the share price at 53p represents a mere £34m Market Cap. The peer average at this point is £ 52m an 80p share price hence, the Biotech is materially undervalued, still +50% increase to go just to the average point plus the stratospheric rises on license terms expected. Also, we have three projects on the brink of licensing, just the one licence deal should come in at many multiples of the current market cap and see us firmly in the £1 to £2 range hence, all to play for.
It's a Red Hot Buy and one of the best risk reward investments on the AIM in my considered opinion but DYOR.
Oh and finally, least I forget, the CEO here is just amazing, new team, new ethos and really cares about the shareholders. Which is totally refreshing compared to others on AIM.
That about covers it but DYOR and follow the links in the previous post.
Good Luck
Pork’s